Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
Aim. To study efficacy and safety of a new dose and dosage form of proxodolol - a beta-adrenoblocker with alpha1-adrenoblocking activity - in patients with moderate arterial hypertension (AH). Material and methods. A total of 60 patients with verified diagnosis of essential AH of the second degree w...
Main Author: | S A Belyaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2011-04-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/30848 |
Similar Items
-
URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01) -
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01) -
BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01) -
Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)